Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vaccines

Free Subscription Articles published in JAMA Retrieve available abstracts of 161 articles: HTML format

Single Articles

November 2021
1. RUBIN R
   COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
   JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
   PubMed    
   
   
   
2. RUBIN R
   Substance Use Disorders and COVID-19 Vaccine Response.
   JAMA. 2021;326:2000.
   PubMed    
   
   
   
3. KUEHN BM
   COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
   JAMA. 2021;326:2002.
   PubMed    
   
   
   
4. KUEHN BM
   Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
   JAMA. 2021;326:2002.
   PubMed    
   
   
   
5. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
   Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
   JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
   PubMed    
   
   
   
6. ABBASI J
   Flu Vaccine Candidate Elicits Enhanced Immune Response.
   JAMA. 2021;326:1784.
   PubMed    
   
   
   
7. ABBASI J
   Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
   JAMA. 2021;326:1784.
   PubMed    
   
   
   
8. ABBASI J
   "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
   JAMA. 2021;326:1784.
   PubMed    
   
   
   
9. 
   Routine Smallpox Vaccination.
   JAMA. 2021;326:1876.
   PubMed    
   
   
   
10. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
    Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
    JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.
    PubMed    
    
    
    
11. MOSS WJ, Gostin LO, Nuzzo JB
    Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
    JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.
    PubMed    
    
    
    
12. KLOMPAS M
    Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
    JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.
    PubMed    
    
    
    
13. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
    Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
    PubMed     Abstract available
    
    
    
14. CROWE EH
    The Taste of Hope.
    JAMA. 2021;326:1683-1684.
    PubMed    
    
    
    
15. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
    Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
    JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.
    PubMed    
    
    
    
16. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed     Abstract available
    
    
    October 2021
17. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
    PubMed    
    
    
    
18. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
    PubMed    
    
    
    
19. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
    PubMed    
    
    
    
20. ABBASI J
    India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
    JAMA. 2021;326:1365.
    PubMed    
    
    
    
21. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.
    PubMed    
    
    
    
22. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.
    PubMed    
    
    
    
23. KUEHN BM
    HPV Vaccination Coverage Has Increased Among Adolescents.
    JAMA. 2021;326:1366.
    PubMed    
    
    
    
24. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
    Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
    JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
    PubMed     Abstract available
    
    
    September 2021
25. RUBIN R
    COVID-19 Vaccine Nasal Spray.
    JAMA. 2021;326:1138.
    PubMed    
    
    
    
26. KRONMAL SL
    Shots in Arms.
    JAMA. 2021;326:1151-1152.
    PubMed    
    
    
    
27. ABBASI J
    SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    JAMA. 2021;326:901.
    PubMed    
    
    
    
28. KUEHN BM
    Adolescent Myocarditis After COVID-19 Vaccination Is Rare.
    JAMA. 2021;326:902.
    PubMed    
    
    
    
29. KHARBANDA EO, Haapala J, DeSilva M, Vazquez-Benitez G, et al
    Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.
    JAMA. 2021 Sep 8. pii: 2784193. doi: 10.1001/jama.2021.15494.
    PubMed    
    
    
    
30. SLOMSKI A
    Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
    JAMA. 2021;326:800.
    PubMed    
    
    
    
31. BLUMENTHAL KG, Phadke NA, Bates DW
    Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.
    PubMed    
    
    
    
32. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
    Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
    PubMed     Abstract available
    
    
    
33. JONES JM, Stone M, Sulaeman H, Fink RV, et al
    Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
    PubMed     Abstract available
    
    
    August 2021
34. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
    PubMed    
    
    
    
35. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
    PubMed    
    
    
    
36. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
    PubMed    
    
    
    
37. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
    PubMed    
    
    
    
38. EVANS A, Webster J, Flores G
    Partnering With the Faith-Based Community to Address Disparities in COVID-19 Vaccination Rates and Outcomes Among US Black and Latino Populations.
    JAMA. 2021;326:609-610.
    PubMed    
    
    
    
39. SCHAEFER GO, Leland RJ, Emanuel EJ
    Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.
    JAMA. 2021 Aug 12. pii: 2783234. doi: 10.1001/jama.2021.13226.
    PubMed    
    
    
    
40. ABBASI J
    Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    JAMA. 2021;326:473.
    PubMed    
    
    
    
41. ABBASI J
    COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
    JAMA. 2021;326:473.
    PubMed    
    
    
    
42. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
    Myocarditis and Pericarditis After Vaccination for COVID-19.
    JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.
    PubMed    
    
    
    July 2021
43. ABBASI J
    Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
    JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.
    PubMed    
    
    
    
44. RUBIN R
    Higher Medicare Payments for In-home COVID-19 Vaccinations.
    JAMA. 2021;326:298.
    PubMed    
    
    
    
45. KUEHN BM
    Resurgence of Pertussis Linked With Switch to Acellular Vaccine.
    JAMA. 2021;326:300.
    PubMed    
    
    
    
46. BENOTMANE I, Gautier G, Perrin P, Olagne J, et al
    Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.
    JAMA. 2021 Jul 23. pii: 2782538. doi: 10.1001/jama.2021.12339.
    PubMed    
    
    
    
47. BATES TA, Leier HC, Lyski ZL, Goodman JR, et al
    Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples.
    JAMA. 2021 Jul 21. pii: 2782428. doi: 10.1001/jama.2021.11656.
    PubMed    
    
    
    
48. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
    PubMed    
    
    
    
49. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
    Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
    PubMed     Abstract available
    
    
    
50. NUTI SV, Armstrong K
    Lay Epidemiology and Vaccine Acceptance.
    JAMA. 2021 Jul 7. pii: 2781943. doi: 10.1001/jama.2021.11130.
    PubMed    
    
    
    
51. WALKEY AJ, Law A, Bosch NA
    Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.
    JAMA. 2021 Jul 2. pii: 2781792. doi: 10.1001/jama.2021.11048.
    PubMed    
    
    
    
52. SANCHEZ VAN KAMMEN M, Heldner MR, Brodard J, Scutelnic A, et al
    Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
    JAMA. 2021 Jul 2. pii: 2781791. doi: 10.1001/jama.2021.9889.
    PubMed     Abstract available
    
    
    
53. KAVANAGH MM, Gostin LO, Sunder M
    Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
    JAMA. 2021 Jul 1. pii: 2781756. doi: 10.1001/jama.2021.10823.
    PubMed    
    
    
    
54. PERSAD G, Emanuel EJ
    Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
    JAMA. 2021 Jul 1. pii: 2781755. doi: 10.1001/jama.2021.11045.
    PubMed    
    
    
    June 2021
55. RUBIN R
    The Search for a Single Vaccine Against Coronaviruses Yet to Come.
    JAMA. 2021 Jun 23. pii: 2781521. doi: 10.1001/jama.2021.9477.
    PubMed    
    
    
    
56. RUBIN R
    Vaccination in Residential Facilities.
    JAMA. 2021;325:2426.
    PubMed    
    
    
    
57. GONZALEZ DC, Nassau DE, Khodamoradi K, Ibrahim E, et al
    Sperm Parameters Before and After COVID-19 mRNA Vaccination.
    JAMA. 2021 Jun 17. pii: 2781360. doi: 10.1001/jama.2021.9976.
    PubMed    
    
    
    
58. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
    PubMed    
    
    
    
59. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
    Realizing the Potential of Maternal Influenza Vaccination.
    JAMA. 2021;325:2257-2259.
    PubMed    
    
    
    
60. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    PubMed     Abstract available
    
    
    
61. TALBOT TR
    COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
    JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.
    PubMed    
    
    
    
62. GOSTIN LO, Shaw J, Salmon DA
    Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
    JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.
    PubMed    
    
    
    
63. RYAN L
    Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
    JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.
    PubMed    
    
    
    
64. WOOD S, Schulman K
    When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
    JAMA. 2021 Jun 2. pii: 2780792. doi: 10.1001/jama.2021.7707.
    PubMed    
    
    
    May 2021
65. HOTEZ PJ, Narayan KMV
    Restoring Vaccine Diplomacy.
    JAMA. 2021 May 28. pii: 2780640. doi: 10.1001/jama.2021.7439.
    PubMed    
    
    
    
66. AL KAABI N, Zhang Y, Xia S, Yang Y, et al
    Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
    JAMA. 2021 May 26. pii: 2780562. doi: 10.1001/jama.2021.8565.
    PubMed     Abstract available
    
    
    
67. RUBIN R
    Allergic Reactions to mRNA Vaccines.
    JAMA. 2021;325:2038.
    PubMed    
    
    
    
68. DALY M, Jones A, Robinson E
    Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021.
    JAMA. 2021 May 24. pii: 2780519. doi: 10.1001/jama.2021.8246.
    PubMed    
    
    
    
69. UYEKI TM, Wentworth DE, Jernigan DB
    Influenza Activity in the US During the 2020-2021 Season.
    JAMA. 2021 May 24. pii: 2780518. doi: 10.1001/jama.2021.6125.
    PubMed    
    
    
    
70. COLLIER AY, McMahan K, Yu J, Tostanoski LH, et al
    Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
    JAMA. 2021 May 13. pii: 2780202. doi: 10.1001/jama.2021.7563.
    PubMed     Abstract available
    
    
    
71. ABBASI J
    Personalized Cancer Vaccine Approach Safe in Early Trial.
    JAMA. 2021;325:1825.
    PubMed    
    
    
    
72. KUEHN BM
    Even Partial COVID-19 Vaccination Protects Nursing Home Residents.
    JAMA. 2021;325:1826.
    PubMed    
    
    
    
73. KUEHN BM
    Vaccine Dramatically Reduces HPV Infection Among Young Women.
    JAMA. 2021;325:1826.
    PubMed    
    
    
    
74. TANG L, Hijano DR, Gaur AH, Geiger TL, et al
    Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
    JAMA. 2021 May 6. pii: 2779854. doi: 10.1001/jama.2021.6564.
    PubMed    
    
    
    
75. ANGEL Y, Spitzer A, Henig O, Saiag E, et al
    Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    JAMA. 2021 May 6. pii: 2779853. doi: 10.1001/jama.2021.7152.
    PubMed     Abstract available
    
    
    
76. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
    JAMA. 2021 May 5. pii: 2779852. doi: 10.1001/jama.2021.7489.
    PubMed    
    
    
    April 2021
77. SEE I, Su JR, Lale A, Woo EJ, et al
    US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    JAMA. 2021 Apr 30. pii: 2779731. doi: 10.1001/jama.2021.7517.
    PubMed     Abstract available
    
    
    
78. KARRON RA, Key NS, Sharfstein JM
    Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine.
    JAMA. 2021 Apr 30. pii: 2779732. doi: 10.1001/jama.2021.7637.
    PubMed    
    
    
    
79. RUBIN R
    Vaccination Priorities Delay Shots for Higher-Risk People of Color.
    JAMA. 2021;325:1601.
    PubMed    
    
    
    
80. RUBIN R
    Medicare Raises Payment for Administering COVID-19 Vaccines.
    JAMA. 2021;325:1601.
    PubMed    
    
    
    
81. CHEN MM, Mott N, Clark SJ, Harper DM, et al
    HPV Vaccination Among Young Adults in the US.
    JAMA. 2021;325:1673-1674.
    PubMed    
    
    
    
82. KUEHN BM
    Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19.
    JAMA. 2021;325:1603.
    PubMed    
    
    
    
83. BLAIN H, Tuaillon E, Gamon L, Pisoni A, et al
    Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose.
    JAMA. 2021 Apr 15. pii: 2778926. doi: 10.1001/jama.2021.6042.
    PubMed    
    
    
    
84. 
    Experts Discuss COVID-19-Variants and Vaccine Efficacy, Immunosuppressed Patients, and More.
    JAMA. 2021 Apr 14. pii: 2778876. doi: 10.1001/jama.2021.5938.
    PubMed    
    
    
    
85. ABBASI J
    Data Leak Exposes Early COVID-19 Vaccine Manufacturing Hiccups.
    JAMA. 2021;325:1385.
    PubMed    
    
    
    
86. PERL SH, Uzan-Yulzari A, Klainer H, Asiskovich L, et al
    SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
    JAMA. 2021 Apr 12. pii: 2778766. doi: 10.1001/jama.2021.5782.
    PubMed    
    
    
    
87. GOSTIN LO, Cohen IG, Shaw J
    Digital Health Passes in the Age of COVID-19: Are "Vaccine Passports" Lawful and Ethical?
    JAMA. 2021 Apr 7. pii: 2778526. doi: 10.1001/jama.2021.5283.
    PubMed    
    
    
    
88. CHAPIN-BARDALES J, Gee J, Myers T
    Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
    JAMA. 2021 Apr 5. pii: 2778441. doi: 10.1001/jama.2021.5374.
    PubMed    
    
    
    March 2021
89. RUBIN R
    HHS Expands Number of People Who Can Vaccinate Against COVID-19.
    JAMA. 2021;325:1134.
    PubMed    
    
    
    
90. GOSTIN LO
    The Coronavirus Pandemic 1 Year On-What Went Wrong?
    JAMA. 2021;325:1132-1133.
    PubMed    
    
    
    
91. EDARA VV, Hudson WH, Xie X, Ahmed R, et al
    Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
    JAMA. 2021 Mar 19. pii: 2777898. doi: 10.1001/jama.2021.4388.
    PubMed    
    
    
    
92. 
    Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
    JAMA. 2021 Mar 17. pii: 2777786. doi: 10.1001/jama.2021.4121.
    PubMed    
    
    
    
93. RUBIN R
    COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.
    JAMA. 2021 Mar 17. pii: 2777785. doi: 10.1001/jama.2021.3370.
    PubMed    
    
    
    
94. WILENSKY GR
    2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
    JAMA. 2021;325:1029-1030.
    PubMed    
    
    
    
95. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
    JAMA. 2021 Mar 15. pii: 2777685. doi: 10.1001/jama.2021.4385.
    PubMed    
    
    
    
96. WILF-MIRON R, Myers V, Saban M
    Incentivizing Vaccination Uptake: The "Green Pass" Proposal in Israel.
    JAMA. 2021 Mar 15. pii: 2777686. doi: 10.1001/jama.2021.4300.
    PubMed    
    
    
    
97. STEPHENSON KE, Le Gars M, Sadoff J, de Groot AM, et al
    Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
    JAMA. 2021 Mar 11. pii: 2777598. doi: 10.1001/jama.2021.3645.
    PubMed     Abstract available
    
    
    
98. CHRISTIE A, Mbaeyi SA, Walensky RP
    CDC Interim Recommendations for Fully Vaccinated People: An Important First Step.
    JAMA. 2021 Mar 10. pii: 2777536. doi: 10.1001/jama.2021.4367.
    PubMed    
    
    
    
99. BLUMENTHAL KG, Robinson LB, Camargo CA Jr, Shenoy ES, et al
    Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    JAMA. 2021 Mar 8. pii: 2777417. doi: 10.1001/jama.2021.3976.
    PubMed    
    
    
    
100. MOORE JP
     Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.
     JAMA. 2021 Mar 4. pii: 2777390. doi: 10.1001/jama.2021.3465.
     PubMed    
     
     
     
101. DEL RIO C, Malani P
     COVID-19 in 2021-Continuing Uncertainty.
     JAMA. 2021 Mar 4. pii: 2777391. doi: 10.1001/jama.2021.3760.
     PubMed    
     
     
     
102. MURRAY CJL, Piot P
     The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
     JAMA. 2021 Mar 3. pii: 2777343. doi: 10.1001/jama.2021.2828.
     PubMed    
     
     
     
103. SAADAT S, Tehrani ZR, Logue J, Newman M, et al
     Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
     JAMA. 2021 Mar 1. pii: 2777171. doi: 10.1001/jama.2021.3341.
     PubMed    
     
     
     
104. LIVINGSTON EH, Malani PN, Creech CB
     The Johnson & Johnson Vaccine for COVID-19.
     JAMA. 2021 Mar 1. pii: 2777172. doi: 10.1001/jama.2021.2927.
     PubMed    
     
     
     February 2021
105. CREECH CB, Walker SC, Samuels RJ
     SARS-CoV-2 Vaccines.
     JAMA. 2021 Feb 26. pii: 2777059. doi: 10.1001/jama.2021.3199.
     PubMed    
     
     
     
106. GHARPURE R, Patel A, Link-Gelles R
     First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
     JAMA. 2021 Feb 24. pii: 2777023. doi: 10.1001/jama.2021.2352.
     PubMed    
     
     
     
107. RUBIN R
     Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
     JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.
     PubMed    
     
     
     
108. RUBIN R
     The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
     JAMA. 2021 Feb 18. pii: 2776787. doi: 10.1001/jama.2021.0641.
     PubMed    
     
     
     
109. WALENSKY RP, Walke HT, Fauci AS
     SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
     JAMA. 2021 Feb 17. pii: 2776739. doi: 10.1001/jama.2021.2294.
     PubMed    
     
     
     
110. KUEHN BM
     High-Income Countries Have Secured the Bulk of COVID-19 Vaccines.
     JAMA. 2021;325:612.
     PubMed    
     
     
     
111. SHARFSTEIN JM, Goodman JL, Borio L
     The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
     JAMA. 2021 Feb 15. pii: 2776658. doi: 10.1001/jama.2021.1961.
     PubMed    
     
     
     
112. SHIMABUKURO TT, Cole M, Su JR
     Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
     JAMA. 2021 Feb 12. pii: 2776557. doi: 10.1001/jama.2021.1967.
     PubMed    
     
     
     
113. 
     Experts Discuss COVID-19-Vaccine Doses, Virus Variants, and More.
     JAMA. 2021 Feb 10. pii: 2776539. doi: 10.1001/jama.2021.1101.
     PubMed    
     
     
     
114. BIANCHI DW, Kaeser L, Cernich AN
     Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
     JAMA. 2021 Feb 10. pii: 2776540. doi: 10.1001/jama.2021.1865.
     PubMed    
     
     
     
115. ADHIKARI EH, Spong CY
     COVID-19 Vaccination in Pregnant and Lactating Women.
     JAMA. 2021 Feb 8. pii: 2776449. doi: 10.1001/jama.2021.1658.
     PubMed    
     
     
     
116. RASMUSSEN SA, Jamieson DJ
     Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
     JAMA. 2021 Feb 8. pii: 2776447. doi: 10.1001/jama.2021.1683.
     PubMed    
     
     
     
117. MEISSNER HC
     A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
     JAMA. 2021 Feb 5. pii: 2776308. doi: 10.1001/jama.2020.26792.
     PubMed    
     
     
     
118. LIVINGSTON EH
     Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
     JAMA. 2021 Feb 3. pii: 2776229. doi: 10.1001/jama.2021.1375.
     PubMed    
     
     
     January 2021
119. JEAN-JACQUES M, Bauchner H
     Vaccine Distribution-Equity Left Behind?
     JAMA. 2021 Jan 29. pii: 2776053. doi: 10.1001/jama.2021.1205.
     PubMed    
     
     
     
120. MOORE JP, Offit PA
     SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
     JAMA. 2021 Jan 28. pii: 2776039. doi: 10.1001/jama.2021.1114.
     PubMed    
     
     
     
121. LONGHURST CA, Kremer B, Maysent PS
     Rapid Implementation of a Vaccination Superstation.
     JAMA. 2021 Jan 28. pii: 2776038. doi: 10.1001/jama.2021.0801.
     PubMed    
     
     
     
122. SHIMABUKURO T, Nair N
     Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
     JAMA. 2021 Jan 21. pii: 2775646. doi: 10.1001/jama.2021.0600.
     PubMed    
     
     
     
123. KUEHN BM
     Drop in Vaccination Causes Surge in Global Measles Cases, Deaths.
     JAMA. 2021;325:213.
     PubMed    
     
     
     
124. ABBASI J
     Broad, Durable Antibody Response in Universal Flu Vaccine Trial.
     JAMA. 2021;325:121.
     PubMed    
     
     
     
125. LARGENT EA, Miller FG
     Problems With Paying People to Be Vaccinated Against COVID-19.
     JAMA. 2021 Jan 6. pii: 2775005. doi: 10.1001/jama.2020.27121.
     PubMed    
     
     
     
126. LAURING AS, Hodcroft EB
     Genetic Variants of SARS-CoV-2-What Do They Mean?
     JAMA. 2021 Jan 6. pii: 2775006. doi: 10.1001/jama.2020.27124.
     PubMed    
     
     
     
127. GOSTIN LO
     A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
     JAMA. 2021;325:17-18.
     PubMed    
     
     
     December 2020
128. GOSTIN LO, Salmon DA, Larson HJ
     Mandating COVID-19 Vaccines.
     JAMA. 2020 Dec 29. pii: 2774712. doi: 10.1001/jama.2020.26553.
     PubMed    
     
     
     
129. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
     National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.
     JAMA. 2020 Dec 29. pii: 2774711. doi: 10.1001/jama.2020.26419.
     PubMed    
     
     
     
130. RUBIN R
     Pharmacies Partner With HHS to Provide COVID-19 Vaccines.
     JAMA. 2020;324:2475.
     PubMed    
     
     
     
131. KUEHN BM
     Global Regulators Set Standards for Safe Vaccines.
     JAMA. 2020;324:2356.
     PubMed    
     
     
     
132. 
     Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
     JAMA. 2020;324:2354-2355.
     PubMed    
     
     
     
133. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
     Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
     JAMA. 2020;324:2415-2422.
     PubMed     Abstract available
     
     
     
134. JIN J
     Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
     JAMA. 2020;324:2452.
     PubMed    
     
     
     
135. RID A, Lipsitch M, Miller FG
     The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
     JAMA. 2020 Dec 14. pii: 2774382. doi: 10.1001/jama.2020.25053.
     PubMed    
     
     
     
136. VOLPP KG, Loewenstein G, Buttenheim AM
     Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program.
     JAMA. 2020 Dec 14. pii: 2774381. doi: 10.1001/jama.2020.24036.
     PubMed    
     
     
     
137. JOFFE S
     Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
     JAMA. 2020 Dec 14. pii: 2774383. doi: 10.1001/jama.2020.25127.
     PubMed    
     
     
     
138. PATEL MM, Uyeki TM
     Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
     JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
     PubMed    
     
     
     
139. VARDENY O, Kim K, Udell JA, Joseph J, et al
     Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
     JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
     PubMed     Abstract available
     
     
     
140. RODRIGUES FMP, Marlow R, Simoes MJ, Danon L, et al
     Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal.
     JAMA. 2020;324:2187-2194.
     PubMed     Abstract available
     
     
     November 2020
141. DESAI AN, Majumder MS
     What Is Herd Immunity?
     JAMA. 2020;324:2113.
     PubMed    
     
     
     
142. LURIE N, Experton B
     How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
     JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.
     PubMed    
     
     
     
143. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
     Bladder Cancer: A Review.
     JAMA. 2020;324:1980-1991.
     PubMed     Abstract available
     
     
     
144. SLOMSKI A
     New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
     JAMA. 2020 Nov 6. pii: 2772859. doi: 10.1001/jama.2020.21706.
     PubMed    
     
     
     
145. UYEKI TM
     High-risk Groups for Influenza Complications.
     JAMA. 2020 Nov 2. pii: 2772692. doi: 10.1001/jama.2020.21869.
     PubMed    
     
     
     
146. UYEKI TM, Santoli J, Jernigan DB
     Preparing for the 2020-2021 Influenza Season.
     JAMA. 2020 Nov 2. pii: 2772691. doi: 10.1001/jama.2020.21849.
     PubMed    
     
     
     October 2020
147. JAKLEVIC MC
     Nursing Homes' Next Test-Vaccinating Workers Against COVID-19.
     JAMA. 2020 Oct 28. pii: 2772581. doi: 10.1001/jama.2020.21354.
     PubMed    
     
     
     
148. BELL BP, Romero JR, Lee GM
     Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
     JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.
     PubMed    
     
     
     
149. LEE GM, Romero JR, Bell BP
     Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
     JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.
     PubMed    
     
     
     
150. GOODMAN JL, Grabenstein JD, Braun MM
     Answering Key Questions About COVID-19 Vaccines.
     JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.
     PubMed    
     
     
     
151. PATEL MM, Jackson ML, Ferdinands J
     Postlicensure Evaluation of COVID-19 Vaccines.
     JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.
     PubMed    
     
     
     
152. SCHMIDT H, Gostin LO, Williams MA
     Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
     JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.
     PubMed    
     
     
     
153. 
     Influenza Vaccine for 2020-2021.
     JAMA. 2020 Oct 2. pii: 2771510. doi: 10.1001/jama.2020.19507.
     PubMed    
     
     
     September 2020
154. STEPHENS DS, McElrath MJ
     COVID-19 and the Path to Immunity.
     JAMA. 2020 Sep 11. pii: 2770758. doi: 10.1001/jama.2020.16656.
     PubMed    
     
     
     August 2020
155. SOLOMON DA, Sherman AC, Kanjilal S
     Influenza in the COVID-19 Era.
     JAMA. 2020 Aug 14. pii: 2769676. doi: 10.1001/jama.2020.14661.
     PubMed    
     
     
     July 2020
156. WIERSINGA WJ, Rhodes A, Cheng AC, Peacock SJ, et al
     Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
     JAMA. 2020 Jul 10. pii: 2768391. doi: 10.1001/jama.2020.12839.
     PubMed     Abstract available
     
     
     
157. DESAI AN, Kim AY
     Management of Hepatitis A in 2020-2021.
     JAMA. 2020 Jul 6. pii: 2768154. doi: 10.1001/jama.2020.4017.
     PubMed    
     
     
     May 2020
158. DEL RIO C, Malani P
     Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
     JAMA. 2020 May 22. pii: 2766600. doi: 10.1001/jama.2020.9252.
     PubMed    
     
     
     
159. HALL MA, Studdert DM
     Privileges and Immunity Certification During the COVID-19 Pandemic.
     JAMA. 2020 May 6. pii: 2765835. doi: 10.1001/jama.2020.7712.
     PubMed    
     
     
     
160. PERSAD G, Emanuel EJ
     The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
     JAMA. 2020 May 6. pii: 2765836. doi: 10.1001/jama.2020.8102.
     PubMed    
     
     
     February 2020
161. WONG JEL, Leo YS, Tan CC
     COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action.
     JAMA. 2020 Feb 20. pii: 2761890. doi: 10.1001/jama.2020.2467.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: